• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒感染中的自然杀伤细胞。

NK cells in SARS-CoV-2 infection.

作者信息

Pituch-Noworolska Anna Marta

机构信息

Department of Immunology, University Children's Hospital of Cracow, Poland.

出版信息

Cent Eur J Immunol. 2022;47(1):95-101. doi: 10.5114/ceji.2022.113078. Epub 2022 Feb 10.

DOI:10.5114/ceji.2022.113078
PMID:35600151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115590/
Abstract

In the SARS-CoV-2 virus pandemic, the questions about specific activity of this virus in induction and/or inhibition of the innate and adaptive immune response are still open. Clinical observations of the severe and critical course of infection showed the hyperinflammation and cytokine storm. In organs and tissues that are a target for viral entry the lymphocytes and monocytes are dominant cells in tissue infiltration. There are different ways and different mechanisms leading to immune response disorders. In peripheral blood in the severe and fatal course of disease lymphopenia is frequent as a poor prognosis factor. Reduced numbers of lymphocytes, mainly T cells and NK cells, are noted in the majority of these patients. The NK cells belonging to the innate immunity system are dedicated to the antiviral response due to production of interferon (IFN) and direct lysis of virus infected cells. In SARS-CoV-2 infection NK cells' activity against this pathogen is impaired based on inhibition of IFN production and functional exhaustion. The restoration of NK cell number and function might support elimination of the SARS-CoV-2 virus, increasing chances of recovery. The use of activated NK cells in SARS-CoV-2 therapy is under clinical trials.

摘要

在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行期间,关于该病毒在诱导和/或抑制先天性和适应性免疫反应方面的特定活性问题仍未解决。对严重和危重症感染病程的临床观察显示存在炎症反应过度和细胞因子风暴。在病毒进入的靶器官和组织中,淋巴细胞和单核细胞是组织浸润中的主要细胞。导致免疫反应紊乱有不同的方式和机制。在疾病的严重和致命病程中,外周血淋巴细胞减少很常见,这是一个预后不良的因素。在大多数此类患者中,淋巴细胞数量减少,主要是T细胞和自然杀伤(NK)细胞。属于先天性免疫系统的NK细胞由于产生干扰素(IFN)和直接裂解病毒感染细胞而致力于抗病毒反应。在SARS-CoV-2感染中,基于IFN产生的抑制和功能耗竭,NK细胞针对该病原体的活性受损。NK细胞数量和功能的恢复可能有助于清除SARS-CoV-2病毒,增加康复机会。在SARS-CoV-2治疗中使用活化的NK细胞正在进行临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/9115590/32ed089386ac/CEJI-47-46310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/9115590/32ed089386ac/CEJI-47-46310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/9115590/32ed089386ac/CEJI-47-46310-g001.jpg

相似文献

1
NK cells in SARS-CoV-2 infection.新型冠状病毒感染中的自然杀伤细胞。
Cent Eur J Immunol. 2022;47(1):95-101. doi: 10.5114/ceji.2022.113078. Epub 2022 Feb 10.
2
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).干扰素-γ:生物学功能与丙型肝炎病毒治疗(I/II型)(共两部分,此为第一部分)
Clin Ter. 2006 Jul-Aug;157(4):377-86.
3
How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery.在新冠病毒攻击期间免疫系统如何变化?新免疫疗法发现的线索。
Curr Med Chem. 2023 Sep 18. doi: 10.2174/0929867331666230918092749.
4
Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.新型冠状病毒感染中白细胞介素-22受体1在血液造血细胞上的独特表达模式
Front Immunol. 2022 Mar 29;13:769839. doi: 10.3389/fimmu.2022.769839. eCollection 2022.
5
IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.人自然杀伤细胞针对 HCV 感染的肝癌细胞产生 IFN-γ 依赖于辅助细胞。
J Hepatol. 2013 Sep;59(3):442-9. doi: 10.1016/j.jhep.2013.04.022. Epub 2013 May 7.
6
Conceptual Framework for SARS-CoV-2-Related Lymphopenia.新型冠状病毒肺炎相关淋巴细胞减少症的概念框架
Adv Biomed Res. 2022 Feb 28;11:16. doi: 10.4103/abr.abr_303_20. eCollection 2022.
7
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.雾化卡介苗接种对恒河猴 SARS-CoV-2 挑战后免疫和疾病参数的影响。
Front Immunol. 2022 Feb 9;12:801799. doi: 10.3389/fimmu.2021.801799. eCollection 2021.
8
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.糖蛋白靶向 CAR-NK 细胞治疗 SARS-CoV-2 感染。
Front Immunol. 2021 Dec 23;12:763460. doi: 10.3389/fimmu.2021.763460. eCollection 2021.
9
A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes.系统生物学方法揭示,组织对西尼罗河病毒的嗜性受抗病毒基因和固有免疫细胞过程的调节。
PLoS Pathog. 2013 Feb;9(2):e1003168. doi: 10.1371/journal.ppat.1003168. Epub 2013 Feb 7.
10
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion.新型冠状病毒病免疫反应的特征:探索失调和衰竭。
Semin Immunol. 2021 Jun;55:101508. doi: 10.1016/j.smim.2021.101508. Epub 2021 Oct 26.

引用本文的文献

1
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women.单细胞RNA测序揭示了新冠康复期孕妇自然杀伤细胞功能的减弱。
Front Immunol. 2025 Jun 30;16:1560391. doi: 10.3389/fimmu.2025.1560391. eCollection 2025.
2
NK Cells: A Powerful Squad Versus SARS-CoV-2.自然杀伤细胞:对抗新冠病毒的强大力量
Int J Mol Sci. 2025 Jul 6;26(13):6500. doi: 10.3390/ijms26136500.
3
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances.自然杀伤细胞在癌症免疫治疗中的作用:机制、逃逸策略及治疗进展

本文引用的文献

1
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.白细胞向肺部及其他部位的迁移:COVID-19 从流感中得到的教训。
Nat Rev Immunol. 2021 Jan;21(1):49-64. doi: 10.1038/s41577-020-00470-2. Epub 2020 Nov 19.
2
Immune Correlates of COVID-19 Control.COVID-19 控制的免疫相关性。
Front Immunol. 2020 Sep 29;11:569611. doi: 10.3389/fimmu.2020.569611. eCollection 2020.
3
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?用于治疗多发性硬化症的药物可激活自然杀伤细胞:它们能预防新冠病毒感染吗?
Biomedicines. 2025 Apr 2;13(4):857. doi: 10.3390/biomedicines13040857.
4
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
5
The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity.自然杀伤细胞对新冠病毒感染、住院情况及严重程度的因果效应。
Inflamm Res. 2025 Feb 13;74(1):37. doi: 10.1007/s00011-024-01967-5.
6
The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.评估新型冠状病毒肺炎中自然杀伤细胞安全性的I期RELEASE临床试验。
iScience. 2024 Dec 27;28(2):111698. doi: 10.1016/j.isci.2024.111698. eCollection 2025 Feb 21.
7
New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit.入住重症监护病房的危重症COVID-19患者新发房颤
J Clin Med. 2023 Nov 8;12(22):6989. doi: 10.3390/jcm12226989.
8
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission.对 COVID-19 患者免疫细胞的多维分析确定了与入院时严重程度相关的细胞亚群。
PLoS Pathog. 2023 Jun 13;19(6):e1011432. doi: 10.1371/journal.ppat.1011432. eCollection 2023 Jun.
9
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome.重组人白细胞介素-2可纠正新冠后综合征患者的自然杀伤细胞表型和功能活性。
Pharmaceuticals (Basel). 2023 Apr 3;16(4):537. doi: 10.3390/ph16040537.
10
COVID-19 and atrial fibrillation: Intercepting lines.2019冠状病毒病与心房颤动:交叉防线
Front Cardiovasc Med. 2023 Jan 23;10:1093053. doi: 10.3389/fcvm.2023.1093053. eCollection 2023.
Infect Drug Resist. 2020 Sep 22;13:3243-3254. doi: 10.2147/IDR.S269797. eCollection 2020.
4
The Immune Response and Immunopathology of COVID-19.新型冠状病毒肺炎的免疫反应和免疫病理学
Front Immunol. 2020 Aug 26;11:2037. doi: 10.3389/fimmu.2020.02037. eCollection 2020.
5
Immunopathology of Hyperinflammation in COVID-19.COVID-19 中的过度炎症的免疫病理学。
Am J Pathol. 2021 Jan;191(1):4-17. doi: 10.1016/j.ajpath.2020.08.009. Epub 2020 Sep 11.
6
Natural Killer Cell Dysfunction and Its Role in COVID-19.自然杀伤细胞功能障碍及其在 COVID-19 中的作用。
Int J Mol Sci. 2020 Sep 1;21(17):6351. doi: 10.3390/ijms21176351.
7
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.SARS-CoV-2 刺突蛋白通过 HLA-E/NKG2A 通路控制自然杀伤细胞的激活。
Cells. 2020 Aug 26;9(9):1975. doi: 10.3390/cells9091975.
8
Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.朋友还是敌人?2020 年 7 月,自然杀伤细胞生物学在 COVID-19 和其他冠状病毒中的已知和未知。
PLoS Pathog. 2020 Aug 26;16(8):e1008820. doi: 10.1371/journal.ppat.1008820. eCollection 2020 Aug.
9
Deciphering SARS-CoV-2 Virologic and Immunologic Features.解析 SARS-CoV-2 的病毒学和免疫学特征。
Int J Mol Sci. 2020 Aug 18;21(16):5932. doi: 10.3390/ijms21165932.
10
NK cells: A double edge sword against SARS-CoV-2.自然杀伤细胞:对抗新冠病毒的双刃剑。
Adv Biol Regul. 2020 Aug;77:100737. doi: 10.1016/j.jbior.2020.100737. Epub 2020 Jun 13.